DIVAT - Données Informatisées et VAlidées en Transplantation

Head :
Giral Magali, Institut de Transplantation Urologie Néphrologie, RTRS “Centaure”, UMR Inserm 1064Centre d'Investigation Clinique et de Biothérapie

Last update : 10/22/2015 | Version : 3 | ID : 21204

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Données Informatisées et VAlidées en Transplantation
Sign or acronym DIVAT
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL (17/09/2004) n°891735, Network DIVAT : 10.16.618
General Aspects
Medical area Urology, andrology and nephrology
Keywords Transplantation
Scientific investigator(s) (Contact)
Name of the director Giral
Surname Magali
Address 30, bd Jean Monnet, 44093 Nantes Cedex 01
Phone +33(0)2.40.08.74.43
Email mgiral@chu-nantes.fr
Unit Institut de Transplantation Urologie Néphrologie, RTRS “Centaure”, UMR Inserm 1064Centre d'Investigation Clinique et de Biothérapie
Organization Centre Hospitalier Universitaire Hôtel Dieu
Collaborations
Funding
Funding status Mixed
Details Each center supports its own costs of creation, follow-up and development.We occasionaly receive a financial support from private pharmaceutical lab.
Governance of the database
Sponsor(s) or organisation(s) responsible Institut de Transplantation Urologie Néphrologie, RTRS “Centaure”, UMR Inserm 1064
Organisation status Public
Additional contact
Main features
Type of database
Type of database Morbidity registers
Additional information regarding sample selection. All recipients of a kidney and/or a pancreas transplant are included in the cohort.
Database objective
Main objective The eight centers established between them collaboration in order to be able to collect and exchange information, to conduct clinical and epidemiological studies all together, to communicate and exchange data and results with other academic researchers, to construct partnership with pharmaceutical industries and to create a biocollection database linked to clinical data (for 3 of the 8 centers).
Inclusion criteria Kidney and/or pancreas transplant recipients
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area Nantes, Nancy, Montpellier, Toulouse, Necker (Paris), Lyon, Saint-Louis (Paris) et Nice
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 1994
Size of the database
Size of the database (number of individuals) [10 000-20 000[ individuals
Details of the number of individuals 11000
Data
Database activity Current data collection
Type of data collected Clinical data
Paraclinical data
Biological data
Administrative data
Clinical data (detail) Direct physical measures
Medical registration
Paraclinical data (detail) Biopsies of the transplant at pre- or post-transplantation. Identification of bacterial, viral, parasitic or mycotic infectious agents.
Biological data (detail) At pre-transplantation : viral status, immunization and only for pancreas transplantations (C-peptide, HbA1C, serum creatinin, serum proteins, serum albumin, LDL, HDL, cholesterol, triglycerides). At post-transplantation : serum creatinin, proteinuria, hemoglobin, LDL, triglycerides, immunization and only for pancreas transplantations (glycemia, C-peptide, HbA1C, insuline, serum amylase, serum lipase, cholesterol).
Administrative data (detail) File number, Cristal number (registration on waiting list), patient contact details and name of referring doctor.
Presence of a biobank Yes
Contents of biobank Whole blood
Serum
Plasma
Blood cells isolated
Fluids (saliva, urine, amniotic fluid, …)
Details of biobank content DMSO CELLS, SERUM, WHOLE BLOOD, TRIZOL CELLS, URINE, PAXGENE, PLASMA
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Data are collected at pre-transplantation and prospectively at each folow-up visit.
Participant monitoring Yes
Details on monitoring of participants Follow-up parameters are collected at 3 months, 6 months, 1 year and then every year.
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://tinyurl.com/PUBMED-DIVAT
Description Liste des publications dans Pubmed
Link to the document http://tinyurl.com/HAL-DIVAT
Description Liste des publications dans HAL
Access
Terms of data access (charter for data provision, format of data, availability delay) The Divat network encourage collaborations and enables interested researchers to submit a research project. Guidelines for requesting data analyses from the registry will be soon available on the DIVAT website.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05